<?xml version='1.0' encoding='UTF-8'?>
<inf:proxyVoteTable xmlns:inf="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/22/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director James C. Momtazee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/22/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Frank P. McCormick</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/22/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Hannah A. Valantine</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>8</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/22/2026</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Ratify Named Executive Officers' Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/22/2026</inf:meetingDate>
    <inf:voteDescription>Advisory Vote on Say on Pay Frequency</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>8</inf:sharesVoted>
        <inf:managementRecommendation>NONE</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
    <inf:voteOtherInfo>Management recommended one year.</inf:voteOtherInfo>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/22/2026</inf:meetingDate>
    <inf:voteDescription>Ratify Deloitte &amp; Touche LLP as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/22/2026</inf:meetingDate>
    <inf:voteDescription>Amend Omnibus Stock Plan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>8</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Madrigal Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>558868105</inf:cusip>
    <inf:isin>US5588681057</inf:isin>
    <inf:meetingDate>06/17/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Julian C. Baker</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Madrigal Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>558868105</inf:cusip>
    <inf:isin>US5588681057</inf:isin>
    <inf:meetingDate>06/17/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Daniel J. Brennan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Madrigal Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>558868105</inf:cusip>
    <inf:isin>US5588681057</inf:isin>
    <inf:meetingDate>06/17/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director James M. Daly</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Madrigal Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>558868105</inf:cusip>
    <inf:isin>US5588681057</inf:isin>
    <inf:meetingDate>06/17/2026</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Ratify Named Executive Officers' Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Madrigal Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>558868105</inf:cusip>
    <inf:isin>US5588681057</inf:isin>
    <inf:meetingDate>06/17/2026</inf:meetingDate>
    <inf:voteDescription>Ratify PricewaterhouseCoopers LLP as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Madrigal Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>558868105</inf:cusip>
    <inf:isin>US5588681057</inf:isin>
    <inf:meetingDate>06/17/2026</inf:meetingDate>
    <inf:voteDescription>Approve Omnibus Stock Plan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Madrigal Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>558868105</inf:cusip>
    <inf:isin>US5588681057</inf:isin>
    <inf:meetingDate>06/17/2026</inf:meetingDate>
    <inf:voteDescription>Approve Qualified Employee Stock Purchase Plan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Arani Bose</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Bridget O'Rourke</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Surbhi Sarna</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Ratify PricewaterhouseCoopers LLP as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Ratify Named Executive Officers' Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Alexis Borisy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>5</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Mark A. Goldsmith</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Ratify PricewaterhouseCoopers LLP as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/18/2026</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Ratify Named Executive Officers' Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Christopher Causey</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Richard Giltner</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Ray Kurzweil</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Jan Malcolm</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Linda Maxwell</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Nilda Mesa</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Judy Olian</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Christopher Patusky</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Martine Rothblatt</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Louis Sullivan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Tommy Thompson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Elect Director Kevin Tracey</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Ratify Named Executive Officers' Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Approve Omnibus Stock Plan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>United Therapeutics Corporation</inf:issuerName>
    <inf:cusip>91307C102</inf:cusip>
    <inf:isin>US91307C1027</inf:isin>
    <inf:meetingDate>06/26/2026</inf:meetingDate>
    <inf:voteDescription>Ratify Ernst &amp; Young LLP as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
    <inf:voteSeries>S000101078</inf:voteSeries>
  </inf:proxyTable>
</inf:proxyVoteTable>
